1. Volume 129, Issue 1, Pages 122-130 (July 2005)
A Randomized Controlled Trial of Radiofrequency Ablation With Ethanol Injection for Small Hepatocellular Carcinoma 
Shuichiro Shiina, Takuma Teratani, Shuntaro Obi, Shinpei Sato, Ryosuke Tateishi, Tomonori Fujishima, Takashi Ishikawa, Yukihiro Koike, Haruhiko Yoshida, Takao Kawabe, Masao Omata 
Gastroenterology 
Volume 129, Issue 1, Pages (July 2005)
DOI: /j.gastro
Copyright © 2005 American Gastroenterological Association Terms and Conditions

2. Figure 1 Flow of participants into the study.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2005 American Gastroenterological Association Terms and Conditions

3. Figure 2
Survival in the 232 eligible patients, according to the treatment group. The actuarial 4-year survival rate was 74% in the radio frequency-ablation group, whereas it was 57% in the ethanol-injection group.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2005 American Gastroenterological Association Terms and Conditions

4. Figure 3
Overall recurrence in the 232 eligible patients, according to the treatment group. The estimated 4-year rate of overall recurrence was 70% in the radiofrequency-ablation group, whereas it was 85% in the ethanol-injection group.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2005 American Gastroenterological Association Terms and Conditions

5. Figure 4
Local tumor progression in the 232 eligible patients, according to the treatment group. The actuarial 4-year rate of local tumor progression was 1.7% in the radiofrequency-ablation group, whereas it was 11% in the ethanol-injection group.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2005 American Gastroenterological Association Terms and Conditions